Abstract
Purpose
Endometrial cancer (EC) is the most common gynecological malignancy and one of few cancers with an increasing US mortality rate. Rural patients may have less access to specialty care affecting their receipt of surgery and adequate lymphadenectomy (AL). We sought to assess rural–urban differences in EC surgery, lymphadenectomy, and survival.
Methods
We analyzed data from the Surveillance Epidemiology and End Results database on EC patients (2004–2013). We performed univariate analyses to compare rural and urban patients on demographic and clinical characteristics and receipt of nodal examination and AL. We assessed rural–urban differences in trends of receipt of AL, performed logistic regression to evaluate differences in receipt of surgery, nodal examination, and AL, and performed survival analysis.
Results
Rural patients were less likely to have any lymph nodes removed, had a smaller median number removed, and a smaller proportion had AL. Even after controlling for established risk factors, rural patients had lower odds of lymph node examination and adequate AL than urban patients and also had poorer survival.
Conclusions
Future research should continue to assess the association between access to care and disparities in surgical care and the effect of these disparities on survival.
Similar content being viewed by others
References
American Cancer Society (2017) Cancer Facts & Figures 2017. American Cancer Society, Atlanta
Jemal A, Ward EM, Johnson CJ et al (2017). Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djx030
Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97–112
Burke WM, Orr J, Leitao M et al (2014) Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 134:385–392
Doll A, Abal M, Rigau M et al (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108:221–229
Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 21:1851–1856
Park JY, Kim EN, Kim DY et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108:486–492
Bansal N, Herzog TJ, Brunner-Brown A et al (2008) The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol 111:208–212
Hsieh CH, ChangChien CC, Lin H et al (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28–33
Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr (1990) Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol 163:1204–1209
Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG (2008) Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol 110:293–298
National Comprehensive Cancer Network (2016) Uterine Neoplasms (Version 1.2017). https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed 9 December 2016
Kitchener HC, Trimble EL, Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup (2009). Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1): 134–140
Sharma C, Deutsch I, Lewin SN et al (2011) Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol 205:562.e561–562.e569
Look KY (2004) Role of lymphadenectomy in management of adenocarcinoma of the endometrium. Eur J Gynaecol Oncol 25:545–551
Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716
Neubauer NL, Lurain JR (2011) The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol 2011:814649
Frost JA, Webster KE, Bryant A, Morrison J (2015). Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007585.pub3
Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136
Chatterjee S, Gupta D, Caputo TA, Holcomb K (2016) Disparities in gynecological malignancies. Front Oncol 6:36. https://doi.org/10.3389/fonc.2016.00036
Foote JR, Gaillard S, Broadwater G et al (2017) Disparities in the surgical staging of high-grade endometrial cancer in the United States. Gynecol Oncol Res Pract 4:1. https://doi.org/10.1186/s40661-016-0036-3. eCollection 2017
Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC (2016) Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis. Gynecol Oncol 143:98–104
Bregar AJ, Alejandro Rauh-Hain J, Spencer R et al (2017) Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis. Gynecol Oncol 145:114–121
Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH (2014) Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 133:353–361
Shalowitz DI, Vinograd AM, Giuntoli RL 2nd (2015). Geographic access to gynecologic cancer care in the United States. Gynecol Oncol 138: 115–120
Tan W, Stehman FB, Carter RL (2009) Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979–2001. Gynecol Oncol 114:346–352
Clemons J, Zahnd WE, Nutt M, Sadowski D, Dynda D, Alanee S (2017) Impact of urologist density and county rurality on the practice of retroperitoneal lymph node dissection and cancer-specific death in patients with nonseminomatous germ cell tumors. J Adolesc Young Adult Oncol 6:83–90
Cole AP, Dalela D, Hanske J et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33:504.e509–517
Chow CJ, Al-Refaie WB, Abraham A et al (2015) Does patient rurality predict quality colon cancer care?: a population-based study. Dis Colon Rectum 58:415–422
Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973-2013 varying) - Linked To County Attributes - Total U.S., 1969-2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2016, based on the November 2015 submission
United States Department of Agriculture (2016) Rural urban continuum codes. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Accessed 17 April 2016
Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J Womens Health (Larchmt) 20:1157–1163
Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ 2nd, Chen VW (1996). Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88: 919–926
Rodriguez AM, Schmeler KM, Kuo YF (2014) Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol 135:525–533
Melamed A, Rauh-Hain JA, Clemmer JT et al (2015) Changing trends in lymphadenectomy for endometrioid adenocarcinoma of the endometrium. Obstet Gynecol 126:815–822
Bogani G, Dowdy SC, Cilby WA, Ghezzi F, Rossetti D, Mariani A (2015) Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res 40(2):301–311
Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY (2009) Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol 27(25):4177–4181. https://doi.org/10.1200/JCO.2008.21.7018
Mannschreck D, Matsuno RK, Moriarty JP et al (2016) Disparities in surgical care among women with endometrial cancer. Obstet Gynecol 128:526–534
Modesitt SC, Huang B, Shelton BJ, Wyatt S (2006) Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence. Gynecol Oncol 103:300–306
Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta D, Schorge JO, del Carmen G (2015). Racial disparities in treatment of high-grade endometrial cancer in the medicare population. Obstet Gynecol 125(4):843–851. https://doi.org/10.1097/AOG.0000000000000605
Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L et al (2011) Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol 29(7):832–838 https://doi.org/10.1200/JCO.2010.31.2124
ACOG Committee Opinion No. 586: Health disparities in rural women (2014). Obstet Gynecol 123:384–388
Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18(3):384–392. https://doi.org/10.1016/S1470-2045(17)30068-2
Acknowledgments
Research reported in this manuscript was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Numbers P20CA192987 (Dr. Laurent Brard) and P20CA192966 (Ms. Sonya Izadi and Dr. Graham Colditz).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Brard reports grants from NIH/NCI, during the conduct of the study.
Rights and permissions
About this article
Cite this article
Zahnd, W.E., Hyon, K.S., Diaz-Sylvester, P. et al. Rural–urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients. Cancer Causes Control 29, 221–232 (2018). https://doi.org/10.1007/s10552-017-0998-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-017-0998-4